BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

31 related articles for article (PubMed ID: 38431441)

  • 1. Brachytherapy in craniopharyngiomas: a systematic review and meta-analysis of long-term follow-up.
    Zhang LY; Guo W; Du HZ; Pan H; Sun YC; Zhu HJ; Song SH; Guo XY; Jiang Y; Sun QQ
    BMC Cancer; 2024 May; 24(1):637. PubMed ID: 38790011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Salvage Reirradiation Options for Locally Recurrent Prostate Cancer: A Systematic Review.
    Zhong J; Slevin F; Scarsbrook AF; Serra M; Choudhury A; Hoskin PJ; Brown S; Henry AM
    Front Oncol; 2021; 11():681448. PubMed ID: 34568012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-dose-rate brachytherapy monotherapy versus low-dose-rate brachytherapy with or without external beam radiotherapy for clinically localized prostate cancer.
    Yamazaki H; Masui K; Suzuki G; Nakamura S; Yamada K; Okihara K; Shiraishi T; Yoshida K; Kotsuma T; Tanaka E; Otani K; Yoshioka Y; Ogawa K
    Radiother Oncol; 2019 Mar; 132():162-170. PubMed ID: 30416045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. F-SHARP: a Phase I/II trial of focal salvage high-dose-rate brachytherapy for Radiorecurrent prostate cancer.
    Solanki AA; Yoo RK; Adams W; Davicioni E; Mysz ML; Shea S; Gupta GN; Showalter T; Garant A; Hentz C; Farooq A; Baldea K; Small W; Harkenrider MM
    BJU Int; 2024 Feb; 133(2):188-196. PubMed ID: 37562825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Focal brachytherapy as definitive treatment for localized prostate cancer: A systematic review and meta-analysis.
    Mohamad O; Nicosia L; Mathier E; Riggenbach E; Zamboglou C; Aebersold DM; Alongi F; Shelan M
    Brachytherapy; 2024; 23(3):309-320. PubMed ID: 38431441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Systematic Review and Meta-analysis of Local Salvage Therapies After Radiotherapy for Prostate Cancer (MASTER).
    Valle LF; Lehrer EJ; Markovic D; Elashoff D; Levin-Epstein R; Karnes RJ; Reiter RE; Rettig M; Calais J; Nickols NG; Dess RT; Spratt DE; Steinberg ML; Nguyen PL; Davis BJ; Zaorsky NG; Kishan AU
    Eur Urol; 2021 Sep; 80(3):280-292. PubMed ID: 33309278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of chronic gastrointestinal and genitourinary toxicities between brachytherapy and external beam radiotherapy for patients with prostate cancer: A systematic review and meta-analysis.
    Li X; Shan L; Wang Q; Zhai H; Xuan Y; Yan G
    Technol Health Care; 2023; 31(S1):357-372. PubMed ID: 37066936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Systematic Review of the Efficacy and Toxicity of Brachytherapy Boost Combined with External Beam Radiotherapy for Nonmetastatic Prostate Cancer.
    Slevin F; Zattoni F; Checcucci E; Cumberbatch MGK; Nacchia A; Cornford P; Briers E; De Meerleer G; De Santis M; Eberli D; Gandaglia G; Gillessen S; Grivas N; Liew M; Linares Espinós EE; Oldenburg J; Oprea-Lager DE; Ploussard G; Rouvière O; Schoots IG; Smith EJ; Stranne J; Tilki D; Smith CT; Van Den Bergh RCN; Van Oort IM; Wiegel T; Yuan CY; Van den Broeck T; Henry AM
    Eur Urol Oncol; 2023 Dec; ():. PubMed ID: 38151440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the safety and efficacy of high-dose rate brachytherapy for radiorecurrent prostate cancer: a systematic review and meta-analysis.
    Shen B; Liu J; Wu D; Guo J
    Strahlenther Onkol; 2024 Feb; ():. PubMed ID: 38386054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A single institution analysis of low-dose-rate brachytherapy: 5-year reported survival and late toxicity outcomes.
    Chao M; Spencer S; Guerrieri M; Ding W; Goharian M; Ho H; Ng M; Healey D; Tan A; Cham C; Joon DL; Lawrentschuk N; Travis D; Sengupta S; Chan Y; Troy A; Pham T; Clarke D; Liodakis P; Bolton D
    J Contemp Brachytherapy; 2018 Apr; 10(2):155-161. PubMed ID: 29789764
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.